Merck advances plan to shed consumer biz

Share this article:

The Wall Street Journal reported today that Merck will begin meeting with potential buyers of its consumer business next week and, citing unnamed sources, wrote that the price tag could be over $10 billion. Merck inherited its consumer business from Schering-Plough, which it acquired in 2009. In an investor note Wednesday night, ISI Group analyst Mark Schoenebaum stated that the final bid will likely be due in late March. Merck consumer products include Coppertone sunscreen, and Claritin allergy medication, among others.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.